Inverted urethral flap reconstruction after partial penectomy: Long-term oncological and functional outcomes.


Journal

Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460

Informations de publication

Date de publication:
04 2022
Historique:
received: 27 10 2021
revised: 26 01 2022
accepted: 08 02 2022
pubmed: 10 3 2022
medline: 21 4 2022
entrez: 9 3 2022
Statut: ppublish

Résumé

Penile aesthetics after partial penectomy (PP) for penile cancer (PC), significantly affect a patient's health-related quality of life (HRQoL), self-esteem, and sexual function. Satisfactory reconstruction has become a major milestone in the treatment of these patients. Clinical charts of all patients that underwent PP and reconstruction with an inverted urethral flap (IUF) were reviewed. The primary endpoints were recurrence-free survival (RFS), overall survival (OS), and progression-free survival (PFS) which were graphically represented by Kaplan-Meier estimates. The key secondary endpoints were Health-related quality of life (HRQoL), erectile function, and lower urinary tract symptoms. Between May 2007 and December 2019, 74 patients with PC underwent PP and IUF reconstruction. The median age was 62 years (IQR 52-76), median follow-up was 72 months (IQR 38-121). Twenty-nine patients (39.2%) underwent inguinal lymph node dissection, 62 (83.8%) underwent dynamic sentinel lymph node biopsy. Kaplan-Meier estimates of OS, RFS, and PFS showed a 6-year OS of 86.5%, 6-year RFS of 90.5%, and a 6-year PFS of 85.1%. Regarding functional outcomes, we found a mean global health score of 84.6% ± 10.4 at the EQ-5D-3L-VAS. The mean Voiding score of the ICIQ-MLUTS was 1.7 ± 3.2 and a mean IIEF-5 score of 17.3 ± 7. To the best of our knowledge, we report the largest cohort in the literature of PP with IUF reconstruction. These results are important since early-stage PC is the most common stage at diagnosis. In carefully selected patients' preservation of a longer urethral stump to allow for the inverted flap is safe and does not compromise oncological outcomes while preserving HRQoL.

Identifiants

pubmed: 35260297
pii: S1078-1439(22)00041-2
doi: 10.1016/j.urolonc.2022.02.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

169.e13-169.e20

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Julián Chavarriaga (J)

Department of Urologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia; Division of Urology, Clinica Imbanaco -Quiron Salud, Cali, Colombia; Division of Urology, Pontificia Universidad Javeriana, Bogotá, Colombia. Electronic address: chavarriagaj@javeriana.edu.co.

Luis Becerra (L)

Department of Urologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.

Diego Camacho (D)

Department of Urologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.

Fabián Godoy (F)

Department of Urologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.

Jorge Forero (J)

Department of Urologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.

Marino Cabrera (M)

Department of Urologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.

Byron López-de-Mesa (B)

Department of Urologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.

Angie Ramirez (A)

Department of Urologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.

Daniel Suso-Palau (D)

Division of Urology, Clinica Imbanaco -Quiron Salud, Cali, Colombia.

Rodolfo Varela (R)

Department of Urologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH